Acrometageria: A spectrum of 'premature aging' syndromes

John M. Greally, L. Y. Boone, S. G. Lenkey, S. L. Wenger, M. W. Steele

Research output: Contribution to journalArticle

18 Citations (Scopus)

Abstract

A child with manifestations of acrogeria and metageria, two 'premature aging' syndromes, is presented. Because of his indistinct phenotype and because the question has been previously raised as to whether these conditions are separate, we propose the designation of acrometageria to describe this phenotypic continuum. As there is much in common clinically between acrometageria and the syndrome of type III procollagen deficiency (Ehlers-Danlos type IV), it might be presumed that a similar pathogenesis for acrometageria exists. This possibility has been tested previously, without demonstrating specific quantitative or qualitative deficits, but with some indirect evidence that collagen metabolism is deranged in these patients. One such crude indicator is the elevation of urinary hyaluronic acid levels, demonstrated in our patient and also observed in the phenotypically distinct Werner and Hutchinson-Gilford premature aging syndromes. On one hand, it could be argued that this supports the concept that premature aging syndromes exist as a biological continuum. On the other hand, it is equally valid to argue that syndromes of premature aging are so described merely because they include recognizable changes of normal aging and that the demonstration of an underlying mutation in a collagen gene, for example, invalidates their study as models of accelerated normal aging.

Original languageEnglish (US)
Pages (from-to)334-339
Number of pages6
JournalAmerican Journal of Medical Genetics
Volume44
Issue number3
DOIs
StatePublished - 1992
Externally publishedYes

Fingerprint

Premature Aging
Collagen
Collagen Type III
Hyaluronic Acid
Gottron type Acrogeria
Phenotype
Mutation
Genes

Keywords

  • acrogeria
  • Ehlers-Danlos
  • hyaluronic acid
  • metageria
  • premature aging
  • progeria
  • type III collagen
  • Werner syndrome

ASJC Scopus subject areas

  • Genetics(clinical)

Cite this

Acrometageria : A spectrum of 'premature aging' syndromes. / Greally, John M.; Boone, L. Y.; Lenkey, S. G.; Wenger, S. L.; Steele, M. W.

In: American Journal of Medical Genetics, Vol. 44, No. 3, 1992, p. 334-339.

Research output: Contribution to journalArticle

Greally, John M. ; Boone, L. Y. ; Lenkey, S. G. ; Wenger, S. L. ; Steele, M. W. / Acrometageria : A spectrum of 'premature aging' syndromes. In: American Journal of Medical Genetics. 1992 ; Vol. 44, No. 3. pp. 334-339.
@article{3312ecc6ecaf48d58190eb28ac3f606d,
title = "Acrometageria: A spectrum of 'premature aging' syndromes",
abstract = "A child with manifestations of acrogeria and metageria, two 'premature aging' syndromes, is presented. Because of his indistinct phenotype and because the question has been previously raised as to whether these conditions are separate, we propose the designation of acrometageria to describe this phenotypic continuum. As there is much in common clinically between acrometageria and the syndrome of type III procollagen deficiency (Ehlers-Danlos type IV), it might be presumed that a similar pathogenesis for acrometageria exists. This possibility has been tested previously, without demonstrating specific quantitative or qualitative deficits, but with some indirect evidence that collagen metabolism is deranged in these patients. One such crude indicator is the elevation of urinary hyaluronic acid levels, demonstrated in our patient and also observed in the phenotypically distinct Werner and Hutchinson-Gilford premature aging syndromes. On one hand, it could be argued that this supports the concept that premature aging syndromes exist as a biological continuum. On the other hand, it is equally valid to argue that syndromes of premature aging are so described merely because they include recognizable changes of normal aging and that the demonstration of an underlying mutation in a collagen gene, for example, invalidates their study as models of accelerated normal aging.",
keywords = "acrogeria, Ehlers-Danlos, hyaluronic acid, metageria, premature aging, progeria, type III collagen, Werner syndrome",
author = "Greally, {John M.} and Boone, {L. Y.} and Lenkey, {S. G.} and Wenger, {S. L.} and Steele, {M. W.}",
year = "1992",
doi = "10.1002/ajmg.1320440313",
language = "English (US)",
volume = "44",
pages = "334--339",
journal = "American Journal of Medical Genetics, Part A",
issn = "1552-4825",
publisher = "Wiley-Liss Inc.",
number = "3",

}

TY - JOUR

T1 - Acrometageria

T2 - A spectrum of 'premature aging' syndromes

AU - Greally, John M.

AU - Boone, L. Y.

AU - Lenkey, S. G.

AU - Wenger, S. L.

AU - Steele, M. W.

PY - 1992

Y1 - 1992

N2 - A child with manifestations of acrogeria and metageria, two 'premature aging' syndromes, is presented. Because of his indistinct phenotype and because the question has been previously raised as to whether these conditions are separate, we propose the designation of acrometageria to describe this phenotypic continuum. As there is much in common clinically between acrometageria and the syndrome of type III procollagen deficiency (Ehlers-Danlos type IV), it might be presumed that a similar pathogenesis for acrometageria exists. This possibility has been tested previously, without demonstrating specific quantitative or qualitative deficits, but with some indirect evidence that collagen metabolism is deranged in these patients. One such crude indicator is the elevation of urinary hyaluronic acid levels, demonstrated in our patient and also observed in the phenotypically distinct Werner and Hutchinson-Gilford premature aging syndromes. On one hand, it could be argued that this supports the concept that premature aging syndromes exist as a biological continuum. On the other hand, it is equally valid to argue that syndromes of premature aging are so described merely because they include recognizable changes of normal aging and that the demonstration of an underlying mutation in a collagen gene, for example, invalidates their study as models of accelerated normal aging.

AB - A child with manifestations of acrogeria and metageria, two 'premature aging' syndromes, is presented. Because of his indistinct phenotype and because the question has been previously raised as to whether these conditions are separate, we propose the designation of acrometageria to describe this phenotypic continuum. As there is much in common clinically between acrometageria and the syndrome of type III procollagen deficiency (Ehlers-Danlos type IV), it might be presumed that a similar pathogenesis for acrometageria exists. This possibility has been tested previously, without demonstrating specific quantitative or qualitative deficits, but with some indirect evidence that collagen metabolism is deranged in these patients. One such crude indicator is the elevation of urinary hyaluronic acid levels, demonstrated in our patient and also observed in the phenotypically distinct Werner and Hutchinson-Gilford premature aging syndromes. On one hand, it could be argued that this supports the concept that premature aging syndromes exist as a biological continuum. On the other hand, it is equally valid to argue that syndromes of premature aging are so described merely because they include recognizable changes of normal aging and that the demonstration of an underlying mutation in a collagen gene, for example, invalidates their study as models of accelerated normal aging.

KW - acrogeria

KW - Ehlers-Danlos

KW - hyaluronic acid

KW - metageria

KW - premature aging

KW - progeria

KW - type III collagen

KW - Werner syndrome

UR - http://www.scopus.com/inward/record.url?scp=0026662918&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0026662918&partnerID=8YFLogxK

U2 - 10.1002/ajmg.1320440313

DO - 10.1002/ajmg.1320440313

M3 - Article

C2 - 1488981

AN - SCOPUS:0026662918

VL - 44

SP - 334

EP - 339

JO - American Journal of Medical Genetics, Part A

JF - American Journal of Medical Genetics, Part A

SN - 1552-4825

IS - 3

ER -